Syntis Bio is a biotechnology company incubated in the Bob Langer Laboratory at MIT, focused on programming synthetic tissue for specific organs (generating a layer of synthetic tissue membrane on the intestinal wall). Initially focused on small intestine-mediated diseases and can be combined with other therapies.